Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012;7(1):e29651.
doi: 10.1371/journal.pone.0029651. Epub 2012 Jan 6.

Dense cranial electroacupuncture stimulation for major depressive disorder--a single-blind, randomized, controlled study

Zhang-Jin Zhang  1 , Roger Ng, Sui Cheung Man, Tsui Yin Jade Li, Wendy Wong, Qing-Rong Tan, Hei Kiu Wong, Ka-Fai Chung, Man-Tak Wong, Wai-Kiu Alfert Tsang, Ka-chee Yip, Eric Ziea, Vivian Taam Wong
Affiliations
Randomized Controlled Trial

Dense cranial electroacupuncture stimulation for major depressive disorder--a single-blind, randomized, controlled study

Zhang-Jin Zhang et al. PLoS One. 2012.

Erratum in

  • PLoS One. 2012 Feb 21;78(8). doi: 10.1371/annotation/b27d20b4-f41c-47af-b19f-a0278c993a2d

Abstract

Background: Previous studies suggest that electroacupuncture possesses therapeutic benefits for depressive disorders. The purpose of this study was to determine whether dense cranial electroacupuncture stimulation (DCEAS) could enhance the antidepressant efficacy in the early phase of selective serotonin reuptake inhibitor (SSRI) treatment of major depressive disorder (MDD).

Methods: In this single-blind, randomized, controlled study, patients with MDD were randomly assigned to 9-session DCEAS or noninvasive electroacupuncture (n-EA) control procedure in combination with fluoxetine (FLX) for 3 weeks. Clinical outcomes were measured using the 17-item Hamilton Depression Rating Scale (HAMD-17), Clinical Global Impression-severity (CGI-S), and Self-rating Depression Scale (SDS) as well as the response and remission rates.

Results: Seventy-three patients were randomly assigned to n-EA (n = 35) and DCEAS (n = 38), of whom 34 in n-EA and 36 in DCEAS group were analyzed. DCEAS-treated patients displayed a significantly greater reduction from baseline in HAMD-17 scores at Day 3 through Day 21 and in SDS scores at Day 3 and Day 21 compared to patients receiving n-EA. DCEAS intervention also produced a higher rate of clinically significant response compared to n-EA procedure (19.4% (7/36) vs. 8.8% (3/34)). The incidence of adverse events was similar in the two groups.

Conclusions: DCEAS is a safe and effective intervention that augments the antidepressant efficacy. It can be considered as an additional therapy in the early phase of SSRI treatment of depressed patients.

Trial registration: Controlled-Trials.com ISRCTN88008690.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Acupoints used in dense cranial electroacupuncture stimulation (DCEAS).
Figure 2
Figure 2. Flowchart of screening and patient recruitment.
n-EA, noninvasive electroacupuncture; DCEAS, dense cranial electroacupuncture stimulation.
Figure 3
Figure 3. Mean changes from baseline in score on the 17-item Hamilton Rating Scale for Depression (HAMD-17), Clinical Global Impression-Severity (CGI-S) and Self-rating Depression Scale (SDS).
Data are expressed as mean with 95% confidence interval (95% CI). * P≤0.037: between-group comparison using Student t-test.
See this image and copyright information in PMC

References

    1. Arroll B, Macgillivray S, Ogston S, Reid I, Sullivan F, et al. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med. 2005;3:449–456. - PMC - PubMed
    1. Blier P, de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci. 1994;15:220–226. - PubMed
    1. Blier P. The pharmacology of putative early-onset antidepressant strategies. Eur Neuropsychopharmacol. 2003;13:57–66. - PubMed
    1. Adell A, Castro E, Celada P, Bortolozzi A, Pazos A, et al. Strategies for producing faster acting antidepressants. Drug Discov Today. 2005;10:578–585. - PubMed
    1. Zhang ZJ, Chen HY, Yip KC, Ng R, Wong VT. The effectiveness and safety of acupuncture therapy in depressive disorders: systematic review and meta-analysis. J Affect Disord. 2010;124:9–21. - PubMed

Publication types

Substances

Associated data